EyePoint (EYPT) Other Working Capital Changes (2010 - 2018)
EyePoint (EYPT) posted Other Working Capital Changes of -$6000.0 for Q1 2026, up 14.29% sequentially from -$7000.0 in Q4 2025, and up 99.97% YoY from -$3000.4 in Q1 2025.
EyePoint (EYPT) Other Working Capital Changes (2010 - 2018) Analysis & Trends
EyePoint has reported Other Working Capital Changes for 9 years, with the latest figure at -$6000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 99.97% year-over-year to -$6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (up 151.76% YoY) and the FY2025 annual result came in at -$33000.0, up 99.89% from the prior year.
- Other Working Capital Changes improved to -$6000.0 in Q1 2026 per EYPT's latest filing, from -$7000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $495000.0 in Q4 2017 and troughed at -$1.1 million in Q1 2014.
- A 5-year average of -$93222.2 and a median of -$9500.0 in 2015 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 36260.61% in 2023, down 6191.22% in 2023.
- Over 5 years, Other Working Capital Changes stood at -$205000.0 in 2022, then sank by 6191.22% to -$12.9 million in 2023, then plunged by 137.62% to -$30.6 million in 2024, then jumped by 99.98% to -$7000.0 in 2025, then increased by 14.29% to -$6000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$6000.0, -$7000.0, and -$8000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -16,000.00 |
| Jun 30, 2018 | -16,000.00 |
| Jun 30, 2018 | -16,000.00 |
| Mar 31, 2018 | -265,000.00 |
| Mar 31, 2018 | -265,000.00 |
| Mar 31, 2018 | -265,000.00 |
| Dec 31, 2017 | 495,000.00 |
| Dec 31, 2017 | 495,000.00 |
| Dec 31, 2017 | 495,000.00 |
| Sep 30, 2017 | -40,000.00 |
| Sep 30, 2017 | -40,000.00 |
| Sep 30, 2017 | -40,000.00 |
| Jun 30, 2017 | -10,000.00 |
| Jun 30, 2017 | -10,000.00 |
| Jun 30, 2017 | -10,000.00 |
| Mar 31, 2017 | 120,000.00 |
| Mar 31, 2017 | 120,000.00 |
| Mar 31, 2017 | 120,000.00 |
| Dec 31, 2016 | -3,000.00 |
| Dec 31, 2016 | -3,000.00 |